MT Receptor

亜型選択性的な製品

シグナル伝達経路

MT Receptorシグナル伝達経路

MT Receptor製品

  • All (7)
  • MT Receptor拮抗剤(1)
  • MT Receptor作動薬(3)
  • 新製品
製品コード 製品名称 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S1204 Melatonin Melatonin is a MT receptor agonist, used as a dietary supplement. Melatonin is a selective ATF-6 inhibitor and downregulates COX-2. Melatonin enhances mitophagy and regulates the homeostasis of apoptosis and autophagy.
Ecotoxicol Environ Saf, 2023, 255:114719
Microbiol Res, 2023, 276:127480
Cell Oncol (Dordr), 2023, 10.1007/s13402-023-00875-w
S1259 Ramelteon Ramelteon (TAK-375) is a novel melatonin receptor agonist for human MT1 and MT2 receptors and chick forebrain melatonin receptors with Ki of 14 pM, 112 pM and 23.1 pM, respectively.
Aging Cell, 2021, e13375
Cell Cycle, 2021, 20(12):1195-1208
Plant Cell Physiol, 2020, 10.1093/pcp/pcaa018
S3584 Luzindole Luzindole (N-0774, N-acetyl-2-benzyltryptamine) is a selective melatonin receptor antagonist with Kis of 179 nM for MT1 and 7.3 nM for MT2, respectively.
Aging Cell, 2021, e13375
Int Immunopharmacol, 2021, 96:107787
S4281 Tasimelteon Tasimelteon (BMS 214778, VEC 162) is a selective dual melatonin receptor (MT1/MT2) agonist with 2.1-4.4 times greater affinity for the MT2 receptor believed to mediate circadian rhythm phase-shifting (Ki = 0.0692 nM and Ki = 0.17 nM in NIH-3T3 and CHOeK1 cells, respectively), than for the MT1 receptor (Ki = 0.304 nM and Ki = 0.35 nM, respectively).
Cells, 2022, 11(21)3467
S1204 Melatonin Melatonin is a MT receptor agonist, used as a dietary supplement. Melatonin is a selective ATF-6 inhibitor and downregulates COX-2. Melatonin enhances mitophagy and regulates the homeostasis of apoptosis and autophagy.
Ecotoxicol Environ Saf, 2023, 255:114719
Microbiol Res, 2023, 276:127480
Cell Oncol (Dordr), 2023, 10.1007/s13402-023-00875-w
S1259 Ramelteon Ramelteon (TAK-375) is a novel melatonin receptor agonist for human MT1 and MT2 receptors and chick forebrain melatonin receptors with Ki of 14 pM, 112 pM and 23.1 pM, respectively.
Aging Cell, 2021, e13375
Cell Cycle, 2021, 20(12):1195-1208
Plant Cell Physiol, 2020, 10.1093/pcp/pcaa018
S4281 Tasimelteon Tasimelteon (BMS 214778, VEC 162) is a selective dual melatonin receptor (MT1/MT2) agonist with 2.1-4.4 times greater affinity for the MT2 receptor believed to mediate circadian rhythm phase-shifting (Ki = 0.0692 nM and Ki = 0.17 nM in NIH-3T3 and CHOeK1 cells, respectively), than for the MT1 receptor (Ki = 0.304 nM and Ki = 0.35 nM, respectively).
Cells, 2022, 11(21)3467
S3584 Luzindole Luzindole (N-0774, N-acetyl-2-benzyltryptamine) is a selective melatonin receptor antagonist with Kis of 179 nM for MT1 and 7.3 nM for MT2, respectively.
Aging Cell, 2021, e13375
Int Immunopharmacol, 2021, 96:107787
S1204 Melatonin Melatonin is a MT receptor agonist, used as a dietary supplement. Melatonin is a selective ATF-6 inhibitor and downregulates COX-2. Melatonin enhances mitophagy and regulates the homeostasis of apoptosis and autophagy.
Ecotoxicol Environ Saf, 2023, 255:114719
Microbiol Res, 2023, 276:127480
Cell Oncol (Dordr), 2023, 10.1007/s13402-023-00875-w
S1259 Ramelteon Ramelteon (TAK-375) is a novel melatonin receptor agonist for human MT1 and MT2 receptors and chick forebrain melatonin receptors with Ki of 14 pM, 112 pM and 23.1 pM, respectively.
Aging Cell, 2021, e13375
Cell Cycle, 2021, 20(12):1195-1208
Plant Cell Physiol, 2020, 10.1093/pcp/pcaa018
S4281 Tasimelteon Tasimelteon (BMS 214778, VEC 162) is a selective dual melatonin receptor (MT1/MT2) agonist with 2.1-4.4 times greater affinity for the MT2 receptor believed to mediate circadian rhythm phase-shifting (Ki = 0.0692 nM and Ki = 0.17 nM in NIH-3T3 and CHOeK1 cells, respectively), than for the MT1 receptor (Ki = 0.304 nM and Ki = 0.35 nM, respectively).
Cells, 2022, 11(21)3467

MT Receptor阻害剤の選択性比較

Tags: MT Receptor inhibitor|MT Receptor agonist|MT Receptor activator|MT Receptor inducer|MT Receptor antagonist|MT Receptor signaling pathway|MT Receptor assay kit